Literature DB >> 23838141

The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.

Peng Wang1, Yingzhe Piao, Xiaohui Zhang, Wenliang Li, Xishan Hao.   

Abstract

PURPOSES: We aimed to investigate the concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid (CSF) and to explore their clinical value in the meningeal carcinomatosis (MC) of lung cancer. So that, sensitive and specificity of CSF examination can be improved in the initial diagnosis of MC.
METHOD: A total of 35 lung cancer patients and 35 patients with benign brain tumor in the same period enrolled in this study. The concentrations of tumor markers CEA, CYFRA 21-1 and NSE in CSF and peripheral blood were examined. RESULT: The concentrations of three tumor markers of CYFRA 21-1, NSE and CEA in blood serum and CSF were obviously higher than that of benign disease group. In MC patients, the concentrations of three tumor markers of CYFRA 21-1, NSE and CEA in blood serum were significant lower than that in CSF. The maximum of Youden's index was identified as the cutoff value of indicator of MC in three tumor markers in CSF which were CEA > 4.7 μg/L, NSE > 14.6 μg/L and CYFRA21-1 > 5.5 μg/L respectively. Based on the cutoff values, the CEA had the highest sensitivity while the CYFRA21-1 had the highest specificitiy. Three tumor markers in the CSF had higher positive rate than those in blood serum. We combined the levels of CEA, NSE and CYFRA21-1 in CSF to diagnosis of MC. Positive of CEA or CYFRA21-1 had the greatest sensitivity of 100% while the specificity of 91.4%; the positive of both CEA and CYFRA21-1 had the highest specificity of 100% while the sensitivity of 74.3%. Both positive predictive value and negative predictive value were 100% when combination positive were confirmed when the all three markers were positive.
CONCLUSION: The combination of CEA and CYFRA21-1 can be recommended in early screening of meningeal carcinoma. Especially, for the patient who was difficult to be diagnosed by CSF histology and MRI, it will be a useful auxiliary marker in diagnosis of MC. The combination of CEA, NSE and CYFRA21-1 can be an effective clinically confirmation and exclusively diagnose indictor of MC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23838141     DOI: 10.3233/CBM-130338

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  23 in total

1.  A magnetic nanoparticle-based time-resolved fluoroimmunoassay for determination of the cytokeratin 19 fragment in human serum.

Authors:  Guanfeng Lin; Tiancai Liu; Jingyuan Hou; Zhiqi Ren; Jianwei Zhou; Qianni Liang; Zhenhua Chen; Wenqi Dong; Yingsong Wu
Journal:  J Fluoresc       Date:  2015-02-10       Impact factor: 2.217

Review 2.  Rare case of pancreatic cancer with leptomeningeal carcinomatosis.

Authors:  In Kyung Yoo; Hong Sik Lee; Chang Duk Kim; Hoon Jai Chun; Yoon Tae Jeen; Bora Keum; Eun Sun Kim; Hyuk Soon Choi; Jae Min Lee; Seung Han Kim; Seung Joo Nam; Jong Jin Hyun
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

3.  Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer.

Authors:  Daniel M Trifiletti; Kara D Romano; Zhiyuan Xu; Kelli A Reardon; Jason Sheehan
Journal:  J Neurooncol       Date:  2015-06-21       Impact factor: 4.130

4.  The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer.

Authors:  Yong Wang; Ningning Luo; Ye Gao; Yaqing Wu; Xueting Qin; Yingxue Qi; Tingting Sun; Rongjie Tao; Chuang Qi; Baoyan Liu; Shuanghu Yuan
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-18       Impact factor: 4.553

5.  Contrast-enhanced magnetic resonance imaging with a novel nano-size contrast agent for the clinical diagnosis of patients with lung cancer.

Authors:  Jianwei Gao; Lei Li; Xia Liu; Rui Guo; Bin Zhao
Journal:  Exp Ther Med       Date:  2018-04-30       Impact factor: 2.447

6.  Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.

Authors:  Xuling Lin; Martin Fleisher; Marc Rosenblum; Oscar Lin; Adrienne Boire; Samuel Briggs; Yevgeniya Bensman; Brenda Hurtado; Larisa Shagabayeva; Lisa M DeAngelis; Katherine S Panageas; Antonio Omuro; Elena I Pentsova
Journal:  Neuro Oncol       Date:  2017-09-01       Impact factor: 12.300

Review 7.  Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.

Authors:  Severa Bunda; Jeffrey A Zuccato; Mathew R Voisin; Justin Z Wang; Farshad Nassiri; Vikas Patil; Sheila Mansouri; Gelareh Zadeh
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 8.  Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies.

Authors:  Tarek Shalaby; Michael A Grotzer
Journal:  Int J Mol Sci       Date:  2015-12-07       Impact factor: 5.923

9.  Evaluation of VEGF-C and tumor markers in bronchoalveolar lavage fluid for lung cancer diagnosis.

Authors:  Chao Cao; Zhong-Bo Chen; Shi-Fang Sun; Yi-Ming Yu; Qun-Li Ding; Zai-Chun Deng
Journal:  Sci Rep       Date:  2013-12-11       Impact factor: 4.379

10.  TGF-β1, IL-6, and TNF-α in bronchoalveolar lavage fluid: useful markers for lung cancer?

Authors:  Zhongbo Chen; Zhiwei Xu; Shifang Sun; Yiming Yu; Dan Lv; Chao Cao; Zaichun Deng
Journal:  Sci Rep       Date:  2014-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.